Detalhe da pesquisa
1.
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.
Lancet Haematol
; 10(8): e624-e632, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532416